Becton, Dickinson and Co. | BDX - Marktkapitalisierung

Aktienkurs
152.14
Täglich Wechseln
-2.71 -1.75%
Monatlich
-3.87%
Jährlich
-25.81%
Q2 Prognose
148.88




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
AngioDynamics USD 511M 94M 2025-09
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Boston Scientific USD 95.61B 2.35B 2026-04
Cooper Companies USD 15.95B 2.05B 2025-12
Danaher USD 140.45B 11.98B 2026-04
Dentsply International USD 2.28B 251M 2025-12
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 47.05B 884M 2026-04
Globus Medical USD 11.69B 3.95B 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
J&J USD 561.65B 17.5B 2026-04
Masimo USD 6.84B 839M 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
WK Kellogg Co USD 13.74B 1.09B 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12